PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | -30.0% | 783 | 0.0% | 0.00% | – |
| Q2 2023 | $736 | -99.5% | 783 | -98.3% | 0.00% | – |
| Q1 2022 | $144,000 | -52.3% | 46,558 | -2.1% | 0.00% | – |
| Q4 2021 | $302,000 | -35.6% | 47,572 | +1.0% | 0.00% | -100.0% |
| Q3 2021 | $469,000 | -22.0% | 47,096 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $601,000 | +17.6% | 45,371 | +55.3% | 0.00% | 0.0% |
| Q1 2021 | $511,000 | -27.1% | 29,221 | +6.6% | 0.00% | 0.0% |
| Q4 2020 | $701,000 | +232.2% | 27,417 | +70.5% | 0.00% | – |
| Q3 2020 | $211,000 | -58.5% | 16,084 | -13.5% | 0.00% | -100.0% |
| Q2 2020 | $508,000 | – | 18,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |